• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特布他林在哮喘中支气管扩张作用的药代动力学-药效学建模

Pharmacokinetic-pharmacodynamic modeling of terbutaline bronchodilation in asthma.

作者信息

Oosterhuis B, Braat M C, Roos C M, Wemer J, Van Boxtel C J

出版信息

Clin Pharmacol Ther. 1986 Oct;40(4):469-75. doi: 10.1038/clpt.1986.208.

DOI:10.1038/clpt.1986.208
PMID:3757410
Abstract

The study of terbutaline pharmacodynamics in patients with asthma is hampered by interfering stimuli when steady-state methods are employed. With pharmacokinetic-dynamic modeling, many of these interferences can be avoided. Using this technique, we studied the effect of terbutaline on lung function in 10 asthmatic patients with greater than 15% lung function reversibility. Terbutaline plasma concentrations, forced expiratory volume in 1 second (FEV1) airway resistance (Raw), and specific airway conductance (sGaw) were measured before and during 7 hours after subcutaneous dosing with 0.75 mg terbutaline. A hyperbolic concentration-effect relation was found. Fitting the time course of the effects required an effect compartment in the integrated model. Thus the delay between plasma concentration and effect time course was characterized by the rate constant ke0. Essentially the same ke0 was found for FEv1, Raw, and sGaw, indicating that the concerning receptors are "localized" in the same pharmacokinetic compartment. Of the lung function measures, sGaw was less sensitive to terbutaline than Raw and FEV1, whereas the latter tended to be the most sensitive one.

摘要

在采用稳态方法时,哮喘患者中特布他林药效学的研究受到干扰刺激的阻碍。通过药代动力学 - 动力学建模,可以避免许多此类干扰。利用这项技术,我们研究了特布他林对10名肺功能可逆性大于15%的哮喘患者肺功能的影响。在皮下注射0.75 mg特布他林之前和之后的7小时内,测量了特布他林血浆浓度、一秒用力呼气量(FEV1)、气道阻力(Raw)和比气道传导率(sGaw)。发现了双曲线浓度 - 效应关系。拟合效应的时间进程需要在综合模型中有一个效应室。因此,血浆浓度和效应时间进程之间的延迟由速率常数ke0表征。对于FEV1、Raw和sGaw,发现了基本相同的ke0,表明相关受体“定位”在同一药代动力学室中。在肺功能测量中,sGaw对特布他林的敏感性低于Raw和FEV1,而后者往往是最敏感的。

相似文献

1
Pharmacokinetic-pharmacodynamic modeling of terbutaline bronchodilation in asthma.特布他林在哮喘中支气管扩张作用的药代动力学-药效学建模
Clin Pharmacol Ther. 1986 Oct;40(4):469-75. doi: 10.1038/clpt.1986.208.
2
The effects of oral and subcutaneous administration of terbutaline in asthmatic patients.特布他林口服与皮下给药对哮喘患者的影响。
Eur J Respir Dis Suppl. 1984;134:181-93.
3
Sites of airway dilatation in asthma following inhaled versus subcutaneous terbutaline. Comparison of physiologic tests with radionuclide lung images.吸入与皮下注射特布他林后哮喘患者气道扩张部位。生理测试与放射性核素肺图像的比较。
Am J Med. 1980 Jan;68(1):14-26. doi: 10.1016/0002-9343(80)90156-4.
4
Bronchodilation and beta 2-selectivity of broxaterol in asthmatics: a crossover, single-blind, terbutaline- and placebo-controlled study.溴沙特罗在哮喘患者中的支气管扩张作用及β2选择性:一项交叉、单盲、以特布他林和安慰剂为对照的研究。
Int J Clin Pharmacol Ther Toxicol. 1992 Oct;30(10):365-70.
5
Effect of aerosol particle size on bronchodilatation with nebulised terbutaline in asthmatic subjects.雾化颗粒大小对哮喘患者雾化特布他林后支气管扩张作用的影响。
Thorax. 1986 May;41(5):364-8. doi: 10.1136/thx.41.5.364.
6
Comparison of three techniques of inhalation on the airway response to terbutaline.三种吸入技术对气道对特布他林反应的比较。
Thorax. 1983 Dec;38(12):908-13. doi: 10.1136/thx.38.12.908.
7
Comparative bronchodilator responses to atropine and terbutaline in asthma and chronic bronchitis.哮喘和慢性支气管炎患者对阿托品和特布他林的支气管扩张反应比较
Chest. 1977 Dec;72(6):719-23. doi: 10.1378/chest.72.6.719.
8
Oral terbutaline in chronic childhood asthma; effects related to plasma concentrations.口服特布他林治疗儿童慢性哮喘;与血药浓度相关的疗效
Eur J Respir Dis Suppl. 1984;134:205-10.
9
Separate and combined use of terbutaline and theophylline in asthmatics. Effects related to plasma levels.
Eur J Respir Dis. 1982 Sep;63(5):399-409.
10
Oral terbutaline alone and in combination with theophylline: dose, plasma concentration, and effect in long-term treatment of bronchial asthma.口服特布他林单独使用及与茶碱联合使用:剂量、血浆浓度及在支气管哮喘长期治疗中的效果
Eur Respir J. 1989 Oct;2(9):861-7.

引用本文的文献

1
Pharmacokinetic-pharmacodynamic modelling: history and perspectives.药代动力学-药效学建模:历史与展望
J Pharmacokinet Pharmacodyn. 2006 Jun;33(3):227-79. doi: 10.1007/s10928-005-9002-0. Epub 2006 Jan 11.
2
Pharmacodynamic modelling of the drug-induced downregulation of a beta 2-adrenoceptor mediated response and lack of restoration of receptor function after a single high dose of prednisone.单次高剂量泼尼松后药物诱导的β2-肾上腺素能受体介导反应下调及受体功能缺乏恢复的药效学模型
Eur J Clin Pharmacol. 1995;49(1-2):37-44. doi: 10.1007/BF00192356.
3
Pharmacokinetic-pharmacodynamic modelling as applied to bronchial asthma.
应用于支气管哮喘的药代动力学-药效学建模
Clin Pharmacokinet. 1995 Oct;29(4):213-20. doi: 10.2165/00003088-199529040-00001.
4
Pharmacokinetic optimisation of asthma treatment.哮喘治疗的药代动力学优化
Clin Pharmacokinet. 1994 May;26(5):396-418. doi: 10.2165/00003088-199426050-00006.
5
The effect of respiratory disorders on clinical pharmacokinetic variables.呼吸系统疾病对临床药代动力学变量的影响。
Clin Pharmacokinet. 1990 Dec;19(6):462-90. doi: 10.2165/00003088-199019060-00004.
6
Clinical pharmacokinetics of beta-agonists.β-激动剂的临床药代动力学
Clin Pharmacokinet. 1990 Apr;18(4):270-94. doi: 10.2165/00003088-199018040-00002.
7
Pharmacokinetic/dynamic correlation of pulmonary and cardiac effects of fenoterol in asthmatic patients after different routes of administration.
Pharm Res. 1992 Mar;9(3):291-7. doi: 10.1023/a:1015839430269.